From: Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy
Strategies
Number (%)
Nafamostat
3 (12.0)
AN69ST membrane
4 (16.0)
PMMA membrane
1 (4.0)